Switch to:
More From Other Websites
Repros Announces November 30, 2015 PDUFA Goal Date for New Drug Application Apr 15 2015
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Apr 15 2015
Repros Announces November 30, 2015 PDUFA Goal Date for New Drug Application Apr 15 2015
REPROS THERAPEUTICS INC. Files SEC form 8-K, Other Events Apr 13 2015
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Apr 08 2015
Repros Gets EU Update on Secondary Hypogonadism Drug - Analyst Blog Apr 07 2015
Repros Receives Confirmation of Eligibility for Submission of a Centralized Marketing Authorization... Apr 06 2015
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Apr 06 2015
Repros Receives Confirmation of Eligibility for Submission of a Centralized Marketing Authorization... Apr 06 2015
Repros' Secondary Hypogonadism Drug Under FDA Review - Analyst Blog Apr 02 2015
Lumber Liquidators, CarMax are big market movers Apr 02 2015
Lumber Liquidators, CarMax are big market movers Apr 02 2015
Repros shares rally on testicle-stimulation drug application Apr 01 2015
Repros Announces Acceptance for Filing of NDA Apr 01 2015
REPROS THERAPEUTICS INC. Files SEC form 8-K, Regulation FD Disclosure Apr 01 2015
Repros Announces Acceptance for Filing of NDA Apr 01 2015
REPROS THERAPEUTICS INC. Financials Mar 20 2015
Repros (RPRX) Incurs Narrower-than-Expected Loss in Q4 - Tale of the Tape Mar 16 2015
Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2014 Financial Results Mar 16 2015
Repros Therapeutics reports 4Q loss Mar 16 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK